Discover where the oligonucleotide field is headed and uncover the opportunities that are often overlooked. This presentation explores why peptide nucleic acids (PNAs) are gaining renewed attention, highlighting their unique advantages and the reasons they have been underutilized despite their exceptional performance. Learn how PNAs can outperform conventional oligonucleotide chemistries across a range of applications, review validated use cases, including cell and gene therapy (CGT), and explore the growing momentum behind their resurgence in the industry. Finally, see how partnering with ChemGenes and Panagene can help accelerate your PNA research with expert guidance, technical support, and the resources needed to bring your next breakthrough closer to reality.